BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang J, Zhang Y, Li C, Ding Y, Hu S, An H. Inhibitory function of Shikonin on MRGPRX2-mediated pseudo-allergic reactions induced by the secretagogue. Phytomedicine 2020;68:153149. [PMID: 32032836 DOI: 10.1016/j.phymed.2019.153149] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Yadav S, Sharma A, Nayik GA, Cooper R, Bhardwaj G, Sohal HS, Mutreja V, Kaur R, Areche FO, Aloudat M, Shaikh AM, Kovács B, Mohamed Ahmed AE. Review of Shikonin and Derivatives: Isolation, Chemistry, Biosynthesis, Pharmacology and Toxicology. Front Pharmacol 2022;13:905755. [DOI: 10.3389/fphar.2022.905755] [Reference Citation Analysis]
2 Jia Q, Fu J, Gao C, Wang H, Wang S, Liang P, Han S, Lv Y, He L. MrgX2-SNAP-tag/cell membrane chromatography model coupled with liquid chromatography-mass spectrometry for anti-pseudo-allergic compound screening in Arnebiae Radix. Anal Bioanal Chem 2022. [PMID: 35697810 DOI: 10.1007/s00216-022-04167-4] [Reference Citation Analysis]
3 Tao T, Chen Y, Lai B, Wang J, Wang W, Xiao W, Cha X. Shikonin combined with methotrexate regulate macrophage polarization to treat psoriasis. Bioengineered 2022;13:11146-55. [PMID: 35485255 DOI: 10.1080/21655979.2022.2062090] [Reference Citation Analysis]
4 Che D, Zheng Y, Hou Y, Li T, Du X, Geng S. Dehydroandrographolide targets CD300f and negatively regulated MRGPRX2-induced pseudo-allergic reaction. Phytother Res 2022. [PMID: 35312106 DOI: 10.1002/ptr.7445] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Chompunud Na Ayudhya C, Ali H. Mas-Related G Protein–Coupled Receptor-X2 and Its Role in Non-immunoglobulin E–Mediated Drug Hypersensitivity. Immunology and Allergy Clinics of North America 2022. [DOI: 10.1016/j.iac.2021.12.003] [Reference Citation Analysis]
6 Mu Z, Guo J, Zhang D, Xu Y, Zhou M, Guo Y, Hou Y, Gao X, Han X, Geng L. Therapeutic Effects of Shikonin on Skin Diseases: A Review. Am J Chin Med 2021;49:1871-95. [PMID: 34961421 DOI: 10.1142/S0192415X21500889] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Sun Q, Gong T, Liu M, Ren S, Yang H, Zeng S, Zhao H, Chen L, Ming T, Meng X, Xu H. Shikonin, a naphthalene ingredient: Therapeutic actions, pharmacokinetics, toxicology, clinical trials and pharmaceutical researches. Phytomedicine 2022;94:153805. [PMID: 34749177 DOI: 10.1016/j.phymed.2021.153805] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
8 Ogasawara H, Noguchi M. Therapeutic Potential of MRGPRX2 Inhibitors on Mast Cells. Cells 2021;10:2906. [PMID: 34831128 DOI: 10.3390/cells10112906] [Reference Citation Analysis]
9 Kim HS, Hashimoto T, Fischer K, Bernigaud C, Chosidow O, Yosipovitch G. Scabies itch: an update on neuroimmune interactions and novel targets. J Eur Acad Dermatol Venereol 2021;35:1765-76. [PMID: 33960033 DOI: 10.1111/jdv.17334] [Reference Citation Analysis]
10 Kumar M, Duraisamy K, Chow BK. Unlocking the Non-IgE-Mediated Pseudo-Allergic Reaction Puzzle with Mas-Related G-Protein Coupled Receptor Member X2 (MRGPRX2). Cells 2021;10:1033. [PMID: 33925682 DOI: 10.3390/cells10051033] [Reference Citation Analysis]
11 McNeil BD. Minireview: Mas-related G protein-coupled receptor X2 activation by therapeutic drugs. Neurosci Lett 2021;751:135746. [PMID: 33610674 DOI: 10.1016/j.neulet.2021.135746] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Kumar M, Singh K, Duraisamy K, A Allam A, Ajarem J, Kwok Chong Chow B. Protective Effect of Genistein against Compound 48/80 Induced Anaphylactoid Shock via Inhibiting MAS Related G Protein-Coupled Receptor X2 (MRGPRX2). Molecules 2020;25:E1028. [PMID: 32106575 DOI: 10.3390/molecules25051028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]